| EIF2B5 |
EIF2B5, EIF2BE: Translation initiation factor eIF-2B subunit epsilon |
NUP214 |
IPI00643352 |
2.895 |
Evidence |
|
| MAPKAPK2 |
MAPKAPK2: MAP kinase-activated protein kinase 2 |
HIST1H4A |
HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H |
2.895 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
VCPIP1 |
VCPIP1, KIAA1850, VCIP135: Deubiquitinating protein VCIP135 |
2.895 |
Evidence |
|
| FGB |
FGB: Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] |
PPBP |
PPBP, CTAP3, SCYB7, TGB1, THBGB1: Platelet basic protein precursor |
2.895 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
2.895 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
DLG1 |
IPI00218729 |
2.895 |
Evidence |
|
| IRS1 |
IRS1: Insulin receptor substrate 1 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
2.895 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
DEF6 |
DEF6, IBP: Differentially expressed in FDCP 6 |
2.895 |
Evidence |
|
| CPD |
CPD: Carboxypeptidase D precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
2.895 |
Evidence |
|
| TMSL8 |
TMSL8, TMSNB: NB thymosin beta |
EEF1A1 |
EEF1A1: Elongation factor 1-alpha |
2.895 |
Evidence |
|
| MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
HMGA2 |
HMGA2, HMGIC: High mobility group protein HMGI-C |
2.895 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
NR5A1 |
NR5A1, AD4BP, FTZF1, SF1: Steroidogenic factor 1 |
2.895 |
Evidence |
|
| SLPI |
SLPI, WAP4, WFDC4: Antileukoproteinase precursor |
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
2.895 |
Evidence |
|
| PLD2 |
PLD2: Phospholipase D2 |
S100A11 |
MLN70, S100A11, S100C: Protein S100-A11 |
2.895 |
Evidence |
|
| HSF1 |
HSF1, HSTF1: Heat shock factor protein 1 |
GAB1 |
GAB1: GRB2-associated-binding protein 1 |
2.895 |
Evidence |
|
| DDIT3 |
DDIT3, CHOP, GADD153: DNA damage-inducible transcript 3 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
2.895 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
2.895 |
Evidence |
|
| IL2RA |
IL2RA: Interleukin-2 receptor alpha chain precursor |
EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
2.895 |
Evidence |
|
| MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
2.895 |
Evidence |
|
| CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
2.895 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
NR4A1 |
CDNA FLJ16818 fis, clone TRACH1000193, highly similar to Orphan nuclear receptor |
2.895 |
Evidence |
|
| IL5 |
IL5: Interleukin-5 precursor |
EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
2.895 |
Evidence |
|
| FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
CHUK |
IPI00556043 |
2.895 |
Evidence |
|
| DLG1 |
IPI00218729 |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
2.895 |
Evidence |
|
| CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
2.895 |
Evidence |
|